Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America et al v. ev3, Inc.
Case Number:
1:10-cv-11822
Court:
Nature of Suit:
Judge:
Firms
- Berger Montague
- Edwards Wildman
- Foley Hoag
- Huggard Law LLC
- Locke Lord
- Ropes & Gray
- Shapiro & Teitelbaum
- Shapiro Weissberg
Companies
Government Agencies
Sectors & Industries:
-
September 30, 2015
1st Circ. Gives Whistleblower Redo In Covidien FCA Suit
The First Circuit told a Massachusetts federal court to rethink blocking a whistleblower from amending his suit alleging a Covidien Ltd. unit got Medicare to illegally fund off-label uses for its blood-blockage device on Wednesday.
-
October 01, 2014
Covidien Unit Escapes FCA Suit Over Off-Label Marketing
A Massachusetts federal judge on Tuesday tossed a whistleblower’s False Claims Act suit accusing a Covidien Ltd. subsidiary of, among other things, promoting off-label uses for its blood-blockage device, saying the suit was precluded by the public disclosure bar and a lack of evidence.